Akhil Deepak Vatvani

7PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPsychopharmacologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 04, 2026
Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-positive advanced or metastatic gastric or gastroesophageal cancer: a meta-analysis of single-arm trials.

|Apr 28, 2026
Pembrolizumab combined with chemotherapy for advanced or metastatic non-small cell lung cancer with low PD-L1 expression: a systematic review and meta-analysis of randomized controlled trials.

|Dec 30, 2025
Authors' reply to the letter to the editor regarding "Low-dose naltrexone for fibromyalgia: a re-analysis suggests lower efficacy than previously reported".

Timotius Ivan Hariyanto, Akhil Deepak Vatvani, Pratik Patel

|Dec 29, 2025
Spleen and Bruton's tyrosine kinase inhibitors for the management of adult immune thrombocytopenia: A systematic review and meta-analysis of randomized controlled trials.

Akhil D Vatvani, Timotius I Hariyanto, Alejandrina C Ramirez

|Oct 06, 2025
Administration of Sodium-Glucose Cotransporter-2 Inhibitors Following Acute Myocardial Infarction: A Systematic Review, Meta-Analysis, and Meta-Regression of Randomized Trials.

Timotius Ivan Hariyanto, Akhil Deepak Vatvani, Theo Audi Yanto

|Sep 17, 2025
Authors' response to comments on "Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis".

Timotius Ivan Hariyanto, Akhil Deepak Vatvani, Pratik Patel

Pageof 2

Frequent Collaborators

5 joint publications

Timotius Ivan Hariyanto

4 joint publications

Theo Audi Yanto

2 joint publications

Nehad Shabarek

1 joint publications

Alejandrina C Ramirez